<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for INCY</title>
    <link />
    <description>Headlines for Incyte Corp</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Incyte Corporation CEO Presents at UBS Global Healthcare Conference (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1448481-incyte-corporation-ceo-presents-at-ubs-global-healthcare-conference-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 20 May 2013 18:34:03 GMT</pubDate>
    </item>
    <item>
      <title>Incyte's Management Presents at Bank of America Merrill Lynch 2013 Health Care Conference (Transcrip</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1438711-incyte-s-management-presents-at-bank-of-america-merrill-lynch-2013-health-care-conference-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 15 May 2013 21:36:06 GMT</pubDate>
    </item>
    <item>
      <title>Is the Biggest Pharma Company in the World the Best Investment?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/07/is-the-biggest-pharma-company-in-the-world-the-bes/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 07 May 2013 14:06:00 GMT</pubDate>
    </item>
    <item>
      <title>Alnylam Narrows Loss, Sales Fall - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98797/alnylam-narrows-loss-sales-fall.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 07 May 2013 08:25:01 GMT</pubDate>
    </item>
    <item>
      <title>Arena Pharma Narrows Loss - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98698/arena-pharma-narrows-loss.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 06 May 2013 11:10:01 GMT</pubDate>
    </item>
    <item>
      <title>Narrower-Than-Expected Loss at Incyte - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98612/narrower-than-expected-loss-at-incyte.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 03 May 2013 14:10:01 GMT</pubDate>
    </item>
    <item>
      <title>Incyte to Present at Upcoming Investor Conferences</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/03/incyte-to-present-at-upcoming-investor-conferences/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 03 May 2013 08:15:00 GMT</pubDate>
    </item>
    <item>
      <title>SHAREHOLDER ALERT: The Law Firm of Levi &amp; Korsinsky Notifies Investors with Losses on Their Investme</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/02/shareholder-alert-the-law-firm-of-levi-korsinsky-n/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 02 May 2013 19:36:16 GMT</pubDate>
    </item>
    <item>
      <title>Incyte's CEO Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1394321-incyte-s-ceo-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 02 May 2013 12:58:04 GMT</pubDate>
    </item>
    <item>
      <title>Optimer's Dificid Cleared Down Under - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98394/optimers-dificid-cleared-down-under.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 01 May 2013 17:28:01 GMT</pubDate>
    </item>
    <item>
      <title>Incyte Corp Ltd (INCY): Today's Featured Health Care Laggard</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11908667/1/incyte-corp-ltd-incy-todays-featured-health-care-laggard.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Mon, 29 Apr 2013 17:01:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Biotech Companies for Young Investors</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/29/3-biotech-companies-for-young-investors/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 29 Apr 2013 13:06:00 GMT</pubDate>
    </item>
    <item>
      <title>BioMarin Widens Loss, Maintains View - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98144/biomarin-widens-loss-maintains-view.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 29 Apr 2013 11:30:01 GMT</pubDate>
    </item>
    <item>
      <title>Incyte Achieves $25 Million Milestone as c-MET Inhibitor INC280 Advances Into Phase II Development</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/29/incyte-achieves-25-million-milestone-as-c-met-inhi/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 29 Apr 2013 09:35:22 GMT</pubDate>
    </item>
    <item>
      <title>Incyte Wins $25M Milestone as c-MET Inhibitor INC280 Moves Into Phase II Trial</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3537174/incyte-wins-25m-milestone-as-c-met-inhibitor-inc280-moves-into-phase-ii-trial.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 29 Apr 2013 08:02:16 GMT</pubDate>
    </item>
    <item>
      <title>Incyte to Report First Quarter 2013 Financial Results on May 2</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/11/incyte-to-report-first-quarter-2013-financial-resu/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 11 Apr 2013 08:20:13 GMT</pubDate>
    </item>
    <item>
      <title>Glancy Binkow &amp; Goldberg LLP Announces Class Action Lawsuit Against Incyte Corporation</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/05/glancy-binkow-goldberg-llp-announces-class-action-/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 05 Apr 2013 21:17:59 GMT</pubDate>
    </item>
    <item>
      <title>Incyte Corp Ltd (INCY): Drugs' Featured Underachiever Of The Day</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11885783/1/incyte-corp-ltd-incy-drugs-featured-underachiever-of-the-day.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Tue, 02 Apr 2013 17:01:00 GMT</pubDate>
    </item>
    <item>
      <title>Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline in the Class Action Lawsuit against</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/25/law-offices-of-howard-g-smith-announces-lead-plain/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 25 Mar 2013 17:50:24 GMT</pubDate>
    </item>
    <item>
      <title>This Week in Biotech</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/23/this-week-in-biotech-20/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 23 Mar 2013 12:00:00 GMT</pubDate>
    </item>
  </channel>
</rss>
